These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2308159)

  • 61. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy.
    Shomrat R; Driks N; Legum C; Shiloh Y
    Am J Med Genet; 1992 Feb; 42(3):281-7. PubMed ID: 1536162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy.
    Thompson MW; Ray PN; Belfall B; Duff C; Logan C; Oss I; Worton RG
    J Med Genet; 1986 Dec; 23(6):548-55. PubMed ID: 2879926
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possibilities and problems in genomic diagnosis of Duchenne muscular dystrophy with molecular probes.
    Speer A; Davies K; McGlade S; Hanke R; Spiegler AW; Szibor R; Sommer D; Herrmann F; Coutelle C
    Biomed Biochim Acta; 1986; 45(7):K19-27. PubMed ID: 2878658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Deletions within the gene of dystrophin in Duchenne and Becker muscular dystrophy].
    Zimowski JG; Bisko M; Fidziańska E; Hausmanowa-Petrusewicz I; Badurska B; Borkowska J; Lusakowska A; Fidziańska A; Jezuita J; Zaremba J
    Neurol Neurochir Pol; 1993; 27(4):469-78. PubMed ID: 8247234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades?
    McGowan R; Challoner BR; Ross S; Holloway S; Joss S; Wilcox D; Holden ST; Tolmie J; Longman C
    Clin Genet; 2013 Feb; 83(2):187-90. PubMed ID: 22428906
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Duchenne muscular dystrophy in South Africa. Prevention by molecular techniques.
    Goldblatt J; Ballo R; Wallis G; Shapera J; Beighton P
    S Afr Med J; 1987 Dec; 72(12):835-7. PubMed ID: 3480586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What do young people think about screening for cystic fibrosis?
    Cobb E; Holloway S; Elton R; Raeburn JA
    J Med Genet; 1991 May; 28(5):322-4. PubMed ID: 1865469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential pitfalls in using DNA probes to counsel Duchenne and Becker muscular dystrophy families.
    Shi YJ; Fischbeck KH; Ritter A
    Chin Med J (Engl); 1992 Jun; 105(6):469-75. PubMed ID: 1451547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Microsatellite analysis of Duchenne muscular dystrophy].
    Fujishita S; Shibuya N
    Nihon Rinsho; 1997 Dec; 55(12):3131-6. PubMed ID: 9436423
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The new genetics: will it pay its way?
    Chapple JC; Dale R; Evans BG
    Lancet; 1987 May; 1(8543):1189-92. PubMed ID: 2883498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transfer of DNA tests from research to routine laboratories: some lessons from the French experience in the case of Duchenne muscular dystrophy.
    Hirtzlin I
    Health Policy; 1996 Jan; 35(1):1-11. PubMed ID: 10172594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular diagnosis of some common genetic diseases in Russia and the former USSR: present and future.
    Baranov VS
    J Med Genet; 1993 Feb; 30(2):141-6. PubMed ID: 8445619
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Demand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987).
    Rona RJ; Swan AV; Beech R; Prentice L; Reynolds A; Wilson O; Mole G; Vadera P
    J Med Genet; 1989 Apr; 26(4):226-36. PubMed ID: 2716033
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defining and Reporting on Critical Values in Genetics: A Laboratory Survey.
    Goh ES; Stavropoulos DJ; Adeli K
    J Appl Lab Med; 2021 Sep; 6(5):1299-1304. PubMed ID: 34086894
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular diagnosis.
    Hoar DI
    Can Fam Physician; 1987 Feb; 33():401-4. PubMed ID: 21263832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scottish consultants: difficulties in laboratories.
    Br Med J; 1980 Mar; 280(6216):810. PubMed ID: 20793075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.